KAN-101

· Kanyos Bio, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KAN-101, covering 2024-03-21 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) [Phase 1, Phase 2]

See pricing